6/16/2014 9:07:34 AM
Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical-stage biopharmaceutical company developing a portfolio of potent new antibiotics designed to be effective against multidrug-resistant bacteria, today announced that the company will participate in upcoming scientific and investor conferences.
Guy Macdonald, Tetraphase President and Chief Executive Officer, will participate in the JMP Securities Healthcare Conference on Wednesday, June 25, at 11:30 a.m. Eastern Time. The conference will take place at the Westin New York Grand Central.
Help employers find you! Check out all the jobs and post your resume.
comments powered by